- Home
- GNLX vs CBAT Comparison
GNLX vs CBAT Comparison
Compare GNLX & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | CBAT |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | China |
| Employees | N/A | 1739 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.4M | 90.4M |
| IPO Year | 2022 | 2025 |
Fundamental Metrics
Financial Performance| Metric | GNLX | CBAT |
|---|---|---|
| Price | $1.99 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.83 | N/A |
| AVG Volume (30 Days) | ★ 439.5K | 247.4K |
| Earning Date | 11-17-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,000.00 | N/A |
| Revenue This Year | N/A | $80.72 |
| Revenue Next Year | N/A | $31.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.86 | $0.46 |
| 52 Week High | $6.26 | $1.55 |
Technical Indicators
Market Signals| Indicator | GNLX | CBAT |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 51.80 |
| Support Level | $1.86 | $0.96 |
| Resistance Level | $2.82 | $1.07 |
| Average True Range (ATR) | 0.23 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 21.97 | 74.95 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Ltd is a high-tech enterprise in China engaged in the development, manufacturing, and sales of new-energy high-power lithium-ion and sodium-ion batteries, as well as the production of raw materials for high-power lithium batteries. The Company's products and solutions are used in electric vehicles, light electric vehicles, energy storage systems, and other high-power applications.